Functional characterization of CEP250 variant identified in nonsyndromic retinitis pigmentosa
Retinitis pigmentosa (RP) is the most common manifestation of inherited retinal diseases with high degree of genetic, allelic, and phenotypic heterogeneity. CEP250 encodes the C‐Nap1 protein and has been associated with various retinal phenotypes. Here, we report the identification of a mutation (c....
Saved in:
Published in: | Human mutation 2019-08, Vol.40 (8), p.1039-1045, Article humu.23759 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | eng |
Subjects: | |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Retinitis pigmentosa (RP) is the most common manifestation of inherited retinal diseases with high degree of genetic, allelic, and phenotypic heterogeneity. CEP250 encodes the C‐Nap1 protein and has been associated with various retinal phenotypes. Here, we report the identification of a mutation (c.562C>T, p.R188*) in the
CEP250 in a consanguineous family with nonsyndromic RP. To gain insights into the molecular pathomechanism underlying
CEP250 defects and the functional relevance of
CEP250 variants in humans, we conducted a functional characterization of
CEP250 variant using a novel
Cep250 knockin mouse line. Remarkably, the disruption of
Cep250 resulted in severe impairment of retinal function and significant retinal morphological alterations. The homozygous knockin mice showed significantly reduced retinal thickness and ERG responses. This study not only broadens the spectrum of phenotypes associated with
CEP250 mutations, but also, for the first time, elucidates the function of CEP250 in photoreceptors using a newly established animal model.
The disruption of Cep250 resulted in severe impairment of retinal function and significant retinal morphological alterations. For the first time, this study investigated the function of CEP250 in photoreceptors using a newly established animal model. |
---|---|
ISSN: | 1059-7794 1098-1004 |